|
1
|
Khan MA, Vikramdeo KS, Sudan SK, Singh S,
Wilhite A, Dasgupta S, Rocconi RP and Singh AP: Platinum-resistant
ovarian cancer: From drug resistance mechanisms to liquid
biopsy-based biomarkers for disease management. Semin Cancer Biol.
77:99–109. 2021.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Kuroki L and Guntupalli SR: Treatment of
epithelial ovarian cancer. BMJ. 371(m3773)2020.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Ohta T, Ohmichi M, Shibuya T, Takahashi T,
Tsutsumi S, Takahashi K and Kurachi H: Gefitinib (ZD1839) increases
the efficacy of cisplatin in ovarian cancer cells. Cancer Biol
Ther. 13:408–416. 2012.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Chelariu-Raicu A, Levenback CF, Slomovitz
BM, Wolf J, Bodurka DC, Kavanagh JJ, Morrison C, Gershenson DM and
Coleman RL: Phase Ib/II study of weekly topotecan and daily
gefitinib in patients with platinum resistant ovarian, peritoneal,
or fallopian tube cancer. Int J Gynecol Cancer. 30:1768–1774.
2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Thibault B and Jean-Claude B: Dasatinib +
Gefitinib, a non platinum-based combination with enhanced growth
inhibitory, anti-migratory and anti-invasive potency against human
ovarian cancer cells. J Ovarian Res. 10(31)2017.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Chang SJ, Liao EC, Yeo HY, Kuo WH, Chen
HY, Tsai YT, Wei YS, Chen YJ, Wang YS, Li JM, et al: Proteomic
investigating the cooperative lethal effect of EGFR and MDM2
inhibitors on ovarian carcinoma. Arch Biochem Biophys. 647:10–32.
2018.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Karami A, Hossienpour M, Mohammadi Noori
E, Rahpyma M, Najafi K and Kiani A: Synergistic effect of gefitinib
and temozolomide on U87MG glioblastoma angiogenesis. utr Cancer.
74:1299–1307. 2022.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Odunsi A, McGray AJR, Miliotto A, Zhang Y,
Wang J, Abiola A, Eppolito C and Huang RY: Fidelity of human
ovarian cancer patient-derived xenografts in a partially humanized
mouse model for preclinical testing of immunotherapies. J
Immunother Cancer. 8(e001237)2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Wen W, Wu J, Liu L, Tian Y, Buettner R,
Hsieh MY, Horne D, Dellinger TH, Han ES, Jove R and Yim JH:
Synergistic anti-tumor effect of combined inhibition of EGFR and
JAK/STAT3 pathways in human ovarian cancer. Mol Cancer.
14(100)2015.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Ji R, Karakatsani ME, Burgess M, Smith M,
Murillo MF and Konofagou EE: Cavitation-modulated inflammatory
response following focused ultrasound blood-brain barrier opening.
J Control Release. 337:458–471. 2021.PubMed/NCBI View Article : Google Scholar
|
|
11
|
de Leon A, Perera R, Nittayacharn P,
Cooley M, Jung O and Exner AA: Ultrasound contrast agents and
delivery systems in cancer detection and therapy. Adv Cancer Res.
139:57–84. 2018.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Deng L, Liu M, Sheng D, Luo Y, Wang D, Yu
X, Wang Z, Ran H and Li P: Low-intensity focused
ultrasound-augmented Cascade chemodynamic therapy via boosting ROS
generation. Biomaterials. 271(120710)2021.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Luo D, Chen W, Wang W, Chen J, Xu H, Chen
J and Wang Y: Low-intensity pulsed ultrasound alleviating
myelosuppression of Sprague-Dawley rats after combined treating by
paclitaxel and carboplatin. Transl Cancer Res. 10:1183–1192.
2021.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Chen TT, Lan TH and Yang FY: Low-intensity
pulsed ultrasound attenuates LPS-induced neuroinflammation and
memory impairment by modulation of TLR4/NF-κB signaling and
CREB/BDNF expression. Cereb Cortex. 29:1430–1438. 2019.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Li F, Park TH, Sankin G, Gilchrist C, Liao
D, Chan CU, Mao Z, Hoffman BD and Zhong P: Mechanically induced
integrin ligation mediates intracellular calcium signaling with
single pulsating cavitation bubbles. Theranostics. 11:6090–6104.
2021.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Gong T, Zhang P, Jia L and Pan Y:
Suppression of ovarian cancer by low-intensity ultrasound through
depletion of IL-6/STAT3 inflammatory pathway-maintained cancer
stemness. Biochem Biophys Res Commun. 526:820–826. 2020.PubMed/NCBI View Article : Google Scholar
|
|
17
|
He J, Liu Z, Zhu X, Xia H and Gao H:
Ultrasonic microbubble cavitation enhanced tissue permeability and
drug diffusion in solid tumor therapy. Pharmaceutics.
14(1642)2022.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Li N, Tang J, Yang J, Zhu B, Wang X, Luo
Y, Yang H, Jang F, Zou J, Liu Z and Wang Z: Tumor perfusion
enhancement by ultrasound stimulated microbubbles potentiates PD-L1
blockade of MC38 colon cancer in mice. Cancer Lett. 498:121–129.
2021.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Dimcevski G, Kotopoulis S, Bjånes T, Hoem
D, Schjøtt J, Gjertsen BT, Biermann M, Molven A, Sorbye H,
McCormack E, et al: A human clinical trial using ultrasound and
microbubbles to enhance gemcitabine treatment of inoperable
pancreatic cancer. J Control Release. 243:172–181. 2016.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Anderson CD, Walton CB and Shohet RV: A
comparison of focused and unfocused ultrasound for
microbubble-mediated gene delivery. Ultrasound Med Biol.
47:1785–1800. 2021.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Matsuo M, Yamaguchi K, Feril LB Jr, Endo
H, Ogawa K, Tachibana K and Nakayama J: Synergistic inhibition of
malignant melanoma proliferation by melphalan combined with
ultrasound and microbubbles. Ultrason Sonochem. 18:1218–1224.
2011.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Chowdhury SM, Abou-Elkacem L, Lee T, Dahl
J and Lutz AM: Ultrasound and microbubble mediated therapeutic
delivery: Underlying mechanisms and future outlook. J Control
Release. 326:75–90. 2020.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Kancheva M, Aronson L, Pattilachan T,
Sautto F, Daines B, Thommes D, Shar A and Razavi M: Bubble-based
drug delivery systems: Next-generation diagnosis to therapy. J
Funct Biomater. 14(373)2023.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Zhang Y, Tang N, Huang L, Qiao W, Zhu Q
and Liu Z: Effect of diagnostic ultrasound and microbubble-enhanced
chemotherapy on metastasis of rabbit VX2 tumor. Med Phys.
48:3927–3935. 2021.PubMed/NCBI View
Article : Google Scholar
|
|
25
|
Hicklin DJ and Ellis LM: Role of the
vascular endothelial growth factor pathway in tumor growth and
angiogenesis. J Clin Oncol. 23:1011–1027. 2005.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Arjaans M, Schröder CP, Oosting SF, Dafni
U, Kleibeuker JE and de Vries EGE: VEGF pathway targeting agents,
vessel normalization and tumor drug uptake: From bench to bedside.
Oncotarget. 7:21247–21258. 2016.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Abou Khouzam R, Brodaczewska K, Filipiak
A, Zeinelabdin NA, Buart S, Szczylik C, Kieda C and Chouaib S:
Tumor hypoxia regulates immune escape/invasion: Influence on
angiogenesis and potential impact of hypoxic biomarkers on cancer
therapies. Front Immunol. 11(613114)2021.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Yang X, Huang M, Zhang Q, Chen J, Li J,
Han Q, Zhang L, Li J, Liu S, Ma Y, et al: Metformin antagonizes
ovarian cancer cells malignancy through MSLN mediated IL-6/STAT3
signaling. Cell Transplant. 30(9636897211027819)2021.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Yang T, Liang C, Chen L, Li J and Geng W:
Low-intensity pulsed ultrasound alleviates hypoxia-induced
chondrocyte damage in temporomandibular disorders by modulating the
hypoxia- inducible factor pathway. Front Pharmacol.
11(689)2020.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Sang F, Xu J, Chen Z, Liu Q and Jiang W:
Low-intensity pulsed ultrasound alleviates osteoarthritis condition
through focal adhesion kinase-mediated chondrocyte proliferation
and differentiation. Cartilage. 13 (2 Suppl):196S–203S.
2021.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Ward M, Wu J and Chiu JF: Experimental
study of the effects of optison concentration on sonoporation in
vitro. Ultrasound Med Biol. 26:1169–1175. 2000.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Caskey CF, Stieger SM, Qin S, Dayton PA
and Ferrara KW: Direct observations of ultrasound microbubble
contrast agent interaction with the microvessel wall. J Acoust Soc
Am. 122:1191–1200. 2007.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Klibanov AL: Ultrasound contrast: Gas
microbubbles in the vasculature. Invest Radiol. 56:50–61.
2021.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Tu J and Yu ACH: Ultrasound-mediated drug
delivery: Sonoporation mechanisms, biophysics, and critical
factors. BME Front. 2022(9807347)2022.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Xiao N, Liu J, Liao L, Sun J, Jin W and
Shu X: Improved delivery of doxorubicin by altering the tumor
microenvironment using ultrasound combined with microbubbles and
chemotherapy. J BUON. 24:844–852. 2019.PubMed/NCBI
|
|
36
|
Xia H, Yang D, He W, Zhu X, Yan Y, Liu Z,
Liu T, Yang J, Tan S, Jiang J, et al: Ultrasound-mediated
microbubbles cavitation enhanced chemotherapy of advanced prostate
cancer by increasing the permeability of blood-prostate barrier.
Transl Oncol. 14(101177)2021.PubMed/NCBI View Article : Google Scholar
|
